Keytruda Qlex: Where’s the invention?
Sept 2025: Two bipartisan bills target patent abuse
June 2025: Still Overpatented, Still Overpriced
May 2025: Merck’s Scheme to Product Hop Keytruda
March 2025: We Need More Drug Patent Data
Feb 2025: Five Patent Predictions for 2025
Dec 2024: The Year in Patent Reform
Oct 2024: The real legacy of the Hatch-Waxman Act
Mar 2024: Why Current Legislation to Prevent Patent Thickets Are a Good Start — But Not Enough
Feb 2024: The Senate HELP Committee Takes Aim at Drug Patent Abuse